Mohammad Beygi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Hypertrophic Cardiomyopathy

Chronic Kidney Disease

End Stage Renal Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Beygi, Salma Ahi, Samaneh Zolghadri, Agata Stanek
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions. Nutrients 16 (14) (2024)
Mohammad Beygi, Salma Ahi, Samaneh Zolghadri, Agata Stanek
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions. Nutrients 16 (14) (2024)
Mohammad Beygi, Salma Ahi, Samaneh Zolghadri, Agata Stanek
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions. Nutrients 16 (14) (2024)
Khatereh Dehghani, Agata Stanek, Arash Bagherabadi, Fatemeh Atashi, Mohammad Beygi, Amirreza Hooshmand, Pezhman Hamedi, Mohsen Farhang, Soghra Bagheri, Samaneh Zolghadri
CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker? Genes 14 (6) (2023)
Khatereh Dehghani, Agata Stanek, Arash Bagherabadi, Fatemeh Atashi, Mohammad Beygi, Amirreza Hooshmand, Pezhman Hamedi, Mohsen Farhang, Soghra Bagheri, Samaneh Zolghadri
CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker? Genes 14 (6) (2023)
Khatereh Dehghani, Agata Stanek, Arash Bagherabadi, Fatemeh Atashi, Mohammad Beygi, Amirreza Hooshmand, Pezhman Hamedi, Mohsen Farhang, Soghra Bagheri, Samaneh Zolghadri
CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker? Genes 14 (6) (2023)